AT317895B - Verfahren zur Herstellung neuer Ester der 2-Alkyl-thiazol-5-carbonsäure sowie deren Säureadditionssalzen - Google Patents

Verfahren zur Herstellung neuer Ester der 2-Alkyl-thiazol-5-carbonsäure sowie deren Säureadditionssalzen

Info

Publication number
AT317895B
AT317895B AT510672A AT510672A AT317895B AT 317895 B AT317895 B AT 317895B AT 510672 A AT510672 A AT 510672A AT 510672 A AT510672 A AT 510672A AT 317895 B AT317895 B AT 317895B
Authority
AT
Austria
Prior art keywords
thiazole
alkyl
preparation
addition salts
carboxylic acid
Prior art date
Application number
AT510672A
Other languages
German (de)
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of AT317895B publication Critical patent/AT317895B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT510672A 1971-06-14 1972-06-14 Verfahren zur Herstellung neuer Ester der 2-Alkyl-thiazol-5-carbonsäure sowie deren Säureadditionssalzen AT317895B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7121466A FR2141526B1 (fr) 1971-06-14 1971-06-14
FR7306847A FR2247243B2 (fr) 1971-06-14 1973-02-27

Publications (1)

Publication Number Publication Date
AT317895B true AT317895B (de) 1974-09-25

Family

ID=26216449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT510672A AT317895B (de) 1971-06-14 1972-06-14 Verfahren zur Herstellung neuer Ester der 2-Alkyl-thiazol-5-carbonsäure sowie deren Säureadditionssalzen

Country Status (10)

Country Link
US (1) US3853875A (fr)
JP (1) JPS5519251A (fr)
AT (1) AT317895B (fr)
BE (1) BE784777A (fr)
CA (1) CA1001629A (fr)
CH (1) CH555362A (fr)
FR (2) FR2141526B1 (fr)
GB (1) GB1382887A (fr)
NL (2) NL176072C (fr)
SE (1) SE389673B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
DE4339617C2 (de) * 1993-11-20 2003-06-05 Vortex Gmbh Dt Rückschlagventil für ein Brauchwasser-Zirkulationssystem
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
WO2000016763A2 (fr) 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Agents antipaludeens
WO2005034949A1 (fr) 2003-09-09 2005-04-21 University Of Florida Derives de desferrithiocine et leur utilisation en tant que chelateurs du fer
CA2603385C (fr) 2005-04-04 2014-07-15 University Of Florida Research Foundation, Inc. Analogues de polyether desferrithiocine et leurs utilisations dans le traitement de conditions telles que la surcharge metallique, la fatigue oxydative et les conditions neoplasiques et pre-neoplasiques
CN104003955A (zh) 2007-03-15 2014-08-27 佛罗里达大学研究基金公司 去铁硫辛聚醚类似物
CN104114170B (zh) 2011-12-16 2021-07-06 佛罗里达大学研究基金会 4′-去铁硫素类似物的用途
EP3071201A4 (fr) 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Analogues de la desferrithiocine et leurs utilisations
WO2016176343A1 (fr) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Agents chélateurs métalliques programmés métaboliquement et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238203A (en) * 1962-10-12 1966-03-01 Olin Mathieson Basic esters of n-alkenoylanthranilic acid
FR2073284B1 (fr) * 1969-12-23 1973-07-13 Ferlux

Also Published As

Publication number Publication date
GB1382887A (en) 1975-02-05
FR2141526B1 (fr) 1975-05-30
DE2228805B2 (de) 1977-03-31
SE389673B (sv) 1976-11-15
JPS5519251A (en) 1980-02-09
FR2141526A1 (fr) 1973-01-26
DE2228805A1 (de) 1972-12-21
CA1001629A (fr) 1976-12-14
NL176072C (nl) 1985-02-18
BE784777A (fr) 1972-12-13
FR2247243B2 (fr) 1976-12-03
NL7208138A (fr) 1972-12-18
FR2247243A2 (fr) 1975-05-09
US3853875A (en) 1974-12-10
NL7908300A (nl) 1980-03-31
CH555362A (fr) 1974-10-31
NL176072B (nl) 1984-09-17

Similar Documents

Publication Publication Date Title
CH537410A (de) Verfahren zur Herstellung neuer Thiazolylessigsäureester
AT317895B (de) Verfahren zur Herstellung neuer Ester der 2-Alkyl-thiazol-5-carbonsäure sowie deren Säureadditionssalzen
AT311938B (de) Verfahren zur Herstellung neuer sekundärer p-Aminophenylamidine sowie deren Säureadditionssalze
AT312580B (de) Verfahren zur Herstellung neuer p-Aminophenylamidine und deren Säureadditionssalze
AT313256B (de) Verfahren zur Herstellung neuer basischer Ester von substituierten Alkylidenaminooxyalkancarbonsäuren und deren Säureadditionssalzen
AT299909B (de) Verfahren zur Herstellung von neuen Sulfamylanthranilsäuren sowie deren Salzen und Estern
AT303704B (de) Verfahren zur Herstellung neuer Benzylidenaminooxyalkancarbonsäuren und deren Salze und Ester
AT318570B (de) Verfahren zur Herstellung neuer 1-Phenoxy-2-hydroxy-3-hydroxyalkylaminopropane sowie deren Säureadditionssalze und Ester
AT308733B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-dioxo-anthracen-2-carbonsäuren sowie deren Salzen und Estern
AT295513B (de) Verfahren zur Herstellung von neuen α-substituierten Indolizinessigsäuren sowie ihren Salzen und Estern
AT317176B (de) Verfahren zur Herstellung neuer Phenylaminoalkane sowie deren Salzen mit physiologisch verträglichen Säuren
AT316561B (de) Verfahren zur Herstellung von neuen Pyridylpiperazinen sowie deren Säureadditionssalzen
CH542839A (de) Verfahren zur Herstellung innerer Benzoesäureester
AT313300B (de) Verfahren zur Herstellung von neuen Guanidinophenylharnstoffderivaten sowie von deren Säureadditionssalzen
AT310757B (de) Verfahren zur Herstellung von neuen Cinnolincarbonsäureestern und von deren pharmazeutisch zulässigen Salzen
CH509303A (de) Verfahren zur Herstellung neuer Cyclopropancarbonsäureester
AT310147B (de) Verfahren zur Herstellung neuer m-Benzoylphenylalkansäureester
AT307387B (de) Verfahren zur Herstellung neuer substituierter 2-Amino-1-phenoxyäthane sowie ihrer Säureadditionssalze
AT306705B (de) Verfahren zur Herstellung von α-substituierten 2-Aminomethyl-benzylalkoholen sowie deren Säureadditionssalzen
AT308110B (de) Verfahren zur Herstellung von Fluorescein-monocarbonsäureestern und deren Salzen
AT321266B (de) Verfahren zur Herstellung neuer N-Aryliminoäther sowie deren Säureadditionssalze
AT330147B (de) Verfahren zur herstellung von 2-methoxy-5-alkylsulfonylbenzamiden sowie deren saureadditionssalzen
AT292732B (de) Verfahren zur Herstellung der neuen cis-Propenylphosphonsäure oder deren Salze oder Ester
AT284813B (de) Verfahren zur Herstellung neuer 3-Amino-5-sulfamylbenzoesäuren sowie deren Salze und Ester
AT320857B (de) Verfahren zur Herstellung von neuen α-Carboxy-2-thienylmethylpenicillinen und α-Carboxy-2-thienylmethylcephalosporinen sowie deren Estern und basischen Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee